Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenefer M Blackwell

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Journal of Leukocyte Biology|December 17, 2004
Slc11a1-mediated resistance to Salmonella enterica serovar Typhimurium and Leishmania donovani infections does not require functional inducible nitric oxide synthase or phagocyte oxidase activityJacqueline K White, Pietro Mastroeni, Jean-François Popoff, et al.
Journal of Bioethical Inquiry|November 29, 2012
Genetic research and aboriginal and Torres Strait Islander AustraliansEmma Kowal, Glenn Pearson, Lobna Rouhani, et al.
Infection and Immunity|November 15, 2006
Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c MiceCarmel B Stober, Uta G Lange, Mark T M Roberts, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 7, 2015
Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil: role of COL1A1Lucas Almeida, Joyce Oliveira, Luiz Henrique Guimarães, et al.
Memorias Do Instituto Oswaldo Cruz|May 12, 2009
Host genetic and epigenetic factors in toxoplasmosisSarra E Jamieson, Heather Cordell, Eskild Petersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infectionCarmel B Stober, Uta G Lange, Mark T M Roberts, et al.
Plos Neglected Tropical Diseases|June 23, 2011
TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)Asha Jayakumar, Tiago M Castilho, Esther Park, et al.
The Journal of Biological Chemistry|October 13, 2007
Evolution of differences in transport function in Slc11a family membersMichala Eichner Techau, Javier Valdez-Taubas, Jean-François Popoff, et al.
Frontiers in Cellular and Infection Microbiology|August 30, 2017
<i>Burkholderia pseudomallei</i> Evades Nramp1 (Slc11a1)- and NADPH Oxidase-Mediated Killing in Macrophages and Exhibits Nramp1-Dependent Virulence Gene ExpressionVeerachat Muangsombut, Patoo Withatanung, Varintip Srinon, et al.
European Journal of Human Genetics : EJHG|February 11, 2005
Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in PolandAnna Dubaniewicz, Sarra E Jamieson, M Dubaniewicz-Wybieralska, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Journal of Leukocyte Biology|December 17, 2004
Slc11a1-mediated resistance to Salmonella enterica serovar Typhimurium and Leishmania donovani infections does not require functional inducible nitric oxide synthase or phagocyte oxidase activityJacqueline K White, Pietro Mastroeni, Jean-François Popoff, et al.
Journal of Bioethical Inquiry|November 29, 2012
Genetic research and aboriginal and Torres Strait Islander AustraliansEmma Kowal, Glenn Pearson, Lobna Rouhani, et al.
Infection and Immunity|November 15, 2006
Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c MiceCarmel B Stober, Uta G Lange, Mark T M Roberts, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 7, 2015
Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil: role of COL1A1Lucas Almeida, Joyce Oliveira, Luiz Henrique Guimarães, et al.
Memorias Do Instituto Oswaldo Cruz|May 12, 2009
Host genetic and epigenetic factors in toxoplasmosisSarra E Jamieson, Heather Cordell, Eskild Petersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infectionCarmel B Stober, Uta G Lange, Mark T M Roberts, et al.
Plos Neglected Tropical Diseases|June 23, 2011
TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)Asha Jayakumar, Tiago M Castilho, Esther Park, et al.
The Journal of Biological Chemistry|October 13, 2007
Evolution of differences in transport function in Slc11a family membersMichala Eichner Techau, Javier Valdez-Taubas, Jean-François Popoff, et al.
Frontiers in Cellular and Infection Microbiology|August 30, 2017
<i>Burkholderia pseudomallei</i> Evades Nramp1 (Slc11a1)- and NADPH Oxidase-Mediated Killing in Macrophages and Exhibits Nramp1-Dependent Virulence Gene ExpressionVeerachat Muangsombut, Patoo Withatanung, Varintip Srinon, et al.
European Journal of Human Genetics : EJHG|February 11, 2005
Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in PolandAnna Dubaniewicz, Sarra E Jamieson, M Dubaniewicz-Wybieralska, et al.
Pageof 11